University of Wisconsin-Madison

presented by
News

UW chairman takes heat over royalties from Medtronic

The old Medtronic Infuse controversy is being stirred up again. The Milwaukee Journal Sentinel today published a story on Thomas Zdeblick, the chairman of the Department of Orthopedics & Rehabilitation at the University of Wisconsin-Madison, who has received more than $25 million in royalties from Medtronic since 2003. The article calls to question Zdeblick’s position […]

Devices & Diagnostics

I-Q Corridor is the stuff of dreamers. Oh, but what a dream!

Ever heard of the I-Q Corridor? Unless you’re an economic development geek, probably not. The concept, first penned in a little-noticed Wisconsin Technology Council white paper, envisions an economic superhighway of sorts connecting the Twin Cities, Madison, Wis. and Chicago along interstates 90 and 94. The “I” stands for ideas, innovation, investment, intellectual property while […]

presented by
News

Stratatech raises $3M for human skin substitute

Stratatech Corp. has raised $3 million to continue developing a genetically engineered human skin substitute, according to a regulatory filing. The fundraise comes in the form of debt, options, warrants or other securities, the document filed with the Securities and Exchange Commission said. Robert Barnard, a company official, declined comment on the funding. The company’s […]

Top Story

MedCity morning read, Wednesday, March 4

A Harvard Medical School Student caused a stir four years ago that has grown into a movement against drug company involvement with medical faculty. Medical schools at Harvard and the University of Wisconsin-Madison are considering strengthening conflict-of-interest rules that guide doctor relationships with drug and medical device companies.